carprofen has been researched along with 4-(5-(4-fluorophenyl)-3-(trifluoromethyl)-1h-pyrazol-1-yl)benzenesulfonamide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Argyle, DJ; Argyle, SA; Kamida, A; Morrison, KO; Pang, LY | 1 |
Becskei, C; Chaudhry, Y; Payne-Johnson, M; Stegemann, MR | 1 |
1 trial(s) available for carprofen and 4-(5-(4-fluorophenyl)-3-(trifluoromethyl)-1h-pyrazol-1-yl)benzenesulfonamide
Article | Year |
---|---|
Comparative efficacy and safety of mavacoxib and carprofen in the treatment of canine osteoarthritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Dog Diseases; Dogs; Double-Blind Method; Female; Inflammation; Male; Osteoarthritis; Pain; Pyrazoles; Treatment Outcome | 2015 |
1 other study(ies) available for carprofen and 4-(5-(4-fluorophenyl)-3-(trifluoromethyl)-1h-pyrazol-1-yl)benzenesulfonamide
Article | Year |
---|---|
The long-acting COX-2 inhibitor mavacoxib (Trocoxilâ„¢) has anti-proliferative and pro-apoptotic effects on canine cancer cell lines and cancer stem cells in vitro.
Topics: Animals; Antineoplastic Agents; Carbazoles; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2 Inhibitors; Dogs; Neoplasm Invasiveness; Neoplastic Stem Cells; Pyrazoles | 2014 |